Sun Pharma Advanced Research Company has reported results for fourth quarter and year ended March 31, 2021.
The company has reported net loss at Rs 56.72 crore for the quarter under review as compared to net loss of Rs 99.54 crore for the same quarter in the previous year. Total income of the company increased by 9.91% at Rs 28.39 crore for Q4FY21 as compared Rs 25.83 crore for the corresponding quarter previous year.
For the year ended March 31, 2021, the company has reported net loss at Rs 151.14 crore as compared to net loss of Rs 312.40 crore for the previous year. Total income of the company reported above 2- fold jump at Rs 258.37 crore for year under review as compared to Rs 86.58 crore for year ended March 31, 2020.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 435.70 |
| Indegene | 486.80 |
| CMS Info Systems | 318.00 |
| JITF Infralogistics | 338.00 |
| Sagility | 42.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: